Long-term treatment with LCZ696 (sacubitril/valsartan) improves cardiac and renal function in stroke-prone spontaneously hypertensive rats

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Professor Yoshiyu Takeda

Kanazawa Medical University, Uchinada (Japan)

9 More presentations in this session

Presentation thumbnail

Rates of adherence to modern antihypertensive drugs in resistant hypertension

Doctor E. Kocianova (Olomouc, CZ)

Abstract Slides

Presentation thumbnail

Non-steroid anti-inflammatory drug consumption decrease antihypertensive treatment efficacy in postenopausal women

Professor N. Izmozherova (Yekaterinburg, RU)

Presentation thumbnail

Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients

Doctor A. Farcas (Cluj Napoca, RO)

Presentation thumbnail

Effect of perindopril/indapamide/amlodipine fixed-dose combination on peripheral and central hemodynamics and vascular wall stiffness parameters in patients with uncontrolled hypertension

Doctor T. Netchessova (Minsk, BY)

Abstract Slides

Presentation thumbnail

CHINA STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive Patients: A one-year registry (CHINA STATUS III)

Mr Z. Du (Beijing, CN)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 2 - Hypertension treatment old and new

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?

Congress Presentation

The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel

Congress Presentation

Hypertension and glucose

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources